wikipedia glp 1 Glucagon-like peptide-1 GLP-1 receptor biology: structure, signaling,

By Product: Ozempic dominates, Tirzepatide products growing fastest Ozempic (semaglutide 0.5mg/1mg/2mg weekly subcutaneous injection) dominated the GLP-1 receptor agonist market with approximately 35.12% market share in 2025, driven by its combination of robust clinical efficacy data, early market entry, broad diabetes label, established prescriber relationships, and expanded off-label use for weight management before Wegovy's commercial scale-up

It also encourages the inclusion of complex carbohydrates and healthy fats while avoiding simple sugars

Insurance is inconsistent

What Is Semaglutide

Im hard-pressed to find a more agonizing quandary for health plan sponsors than the decision to cover glucagon-like peptide-1 (GLP-1) agonists for weight loss for their plan members (and their dependents)